VO-OHpic, an inhibitor of PTEN, relieves the inhibition of the mTOR signaling pathway, weakens lipid metabolism, and effectively promotes the activation of anti-tumor immunity after chemotherapy [86]. Here, MTOR is linked to neoplasm.